Skip to content

Trilogy 100 Ventilator

by Respironics Inc., Sleep & Home Respiratory Group

510(k) K083526

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

3 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Abbreviated NumberK083526 Date13 Mar 2009ClearedStatusActive

Recalls

8 recalls · 3 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-0882-2023 FDA Class I initiated 7 Dec 2022
    • Ongoing Z-0884-2023 FDA Class I initiated 7 Dec 2022

    The replacement silicone sound abatement foam installed into some Trilogy 100 and Trilogy 200 devices may separate from the plastic backing to which it is attached. If this were to happen, the foam could potentially block air inlet, which could result in a reduction in delivered therapy volume or pressure and could cause the device to alarm.

    • Ongoing Z-1956-2021 FDA Class I initiated 14 Jun 2021

    The polyester-based polyurethane (PE-PUR) foam may degrade into particles which may enter the devices air pathway and be ingested or inhaled by the user, and the PE-PUR foam may off-gas certain chemicals.

    • Terminated Z-1065-2016 FDA Class II initiated 18 Jan 2016

    Software Issue

    • Terminated Z-1143-2014 FDA Class I initiated 11 Feb 2014

    Internal testing revealed a potentially defective component on the power management board that could affect the function of certain Trilogy Ventilators resulting in loss of therapy to patients.

    • Terminated Z-2024-2012 FDA Class I initiated 27 Apr 2012

    The specified Trilogy units are being recalled because of the potential for a faulty component in the power supply.

    • Terminated Z-0296-2012 FDA Unclassified (pre-2012) initiated 11 Oct 2011

    Trilogy 100, 200 and 202 units are being recalled due to low impeller press-force used during the manufacturing process. If the press force were low enough, theoretically the impeller could move up the shaft and come into contact with the inside of the blower housing/impeller enclosure. This may impact therapy.

    • Terminated Z-1896-2010 FDA Unclassified (pre-2012) initiated 10 Jun 2010

    It is possible that the battery could electrically short, resulting in a potential for fire or a thermal event.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CBK
Device Class
Class II
Regulation
21 CFR Part 868.5895
Advisory Committee
Anesthesiology
FDA Decision
SESE Substantially Equivalent

Other devices from Respironics Inc., Sleep & Home Respiratory Group

See all devices from Respironics Inc., Sleep & Home Respiratory Group →